Victoroff J, Mack W J, Lyness S A, Chui H C
University of Southern California School of Medicine, Rancho Los Amigos Medical Center, Downey 90242, USA.
Am J Psychiatry. 1995 Oct;152(10):1476-84. doi: 10.1176/ajp.152.10.1476.
The aim of the present study was to determine the accuracy of clinical diagnoses of dementia in a large group of patients evaluated in a multicenter, university-based, Alzheimer's disease diagnostic and treatment program.
Clinical diagnoses and neuropathological results from seven collaborating Alzheimer's disease research centers were compared for 196 cases of dementia.
When diagnoses of probable Alzheimer's disease, possible Alzheimer's disease, and Alzheimer's disease plus another condition were combined, 163 (83%) of the patients were clinically regarded as likely to have had Alzheimer's disease. Of those patients, 134 (82%) were found to have neuropathological changes diagnostic of Alzheimer's disease or Alzheimer's disease plus another condition. A total of 116 patients were diagnosed as having probable Alzheimer's disease; 100 (86%) of those were found to have pathological diagnoses of Alzheimer's disease or Alzheimer's disease plus another condition. Cerebral infarcts were found in 17% of the patients clinically diagnosed with probable Alzheimer's disease. Lewy bodies with variable Alzheimer's disease-type pathological changes were found in 7% of the patients with clinical diagnoses of probable Alzheimer's disease. Conversely, significant Alzheimer's disease-type pathological changes were found in 55% of the patients clinically diagnosed as having vascular dementia.
Clinicians accurately predict Alzheimer's disease-type neuropathological findings in a high proportion of cases of dementia but may not predict cerebrovascular pathology and Lewy bodies in some patients with apparent clinical Alzheimer's disease and may often fail to predict Alzheimer's disease-type pathological findings in patients with apparent vascular dementia. With the emergence of effective treatments for Alzheimer's disease, there is an increasing need to optimize methods for ante-mortem diagnosis of dementia.
本研究旨在确定在一个基于大学的多中心阿尔茨海默病诊断与治疗项目中接受评估的一大组患者中,痴呆临床诊断的准确性。
比较了七个合作的阿尔茨海默病研究中心对196例痴呆患者的临床诊断和神经病理学结果。
当将可能的阿尔茨海默病、可能的阿尔茨海默病以及阿尔茨海默病合并另一种疾病的诊断合并计算时,163例(83%)患者临床上被认为可能患有阿尔茨海默病。在这些患者中,134例(82%)被发现有诊断为阿尔茨海默病或阿尔茨海默病合并另一种疾病的神经病理学改变。共有116例患者被诊断为可能的阿尔茨海默病;其中100例(86%)被发现有阿尔茨海默病或阿尔茨海默病合并另一种疾病的病理诊断。在临床诊断为可能的阿尔茨海默病的患者中,17%发现有脑梗死。在临床诊断为可能的阿尔茨海默病的患者中,7%发现有伴有不同程度阿尔茨海默病类型病理改变的路易体。相反,在临床诊断为血管性痴呆的患者中,55%发现有显著的阿尔茨海默病类型病理改变。
临床医生在很大比例的痴呆病例中能准确预测阿尔茨海默病类型的神经病理学发现,但在一些明显患有临床阿尔茨海默病的患者中可能无法预测脑血管病变和路易体,并且在明显患有血管性痴呆的患者中常常无法预测阿尔茨海默病类型的病理发现。随着阿尔茨海默病有效治疗方法的出现,优化痴呆生前诊断方法的需求日益增加。